Synageva BioPharma Corp. (NASDAQ:GEVA)

CAPS Rating: 1 out of 5

Results 1 - 1 of 1

Recs

1
Member Avatar IBDContrarian (25.32) Submitted: 7/23/2012 1:45:33 PM : Underperform Start Price: $49.14 GEVA Score: -11.64

IBD EPS, RS, SPROE, Acc ratings plus P/E and div yield
MED 3 99 ..A NEG

Name: SyngvBioPh

Results 1 - 1 of 1

Featured Broker Partners


Advertisement